Sector: Oncology Service
Title: Safety and potential efficacy of 20% v/v tigilanol tiglate (0.2 mg/cm3 lesion volume) in the treatment of grey horse melanomas Investigators: Corey Saba, DVM,…
Investigators: Corey Saba, DVM, DACVIM (Oncology faculty) Jarred Williams, DVM, DACVS-LA (Equine faculty) If interested, please have your primary veterinarian request additional information through the…
Phase II evaluation of single agent cyclophosphamide for feline lymphoma Investigators: Corey Saba, DVM, DACVIM (Oncology faculty) Travis Laver, PhD, VMD, DACVIM (Oncology faculty) Brittany…
Study to Determine the Safety and Efficacy of TANOVEATM (Rabacfosadine for Injection) in Cats with Lymphoma Using a Dose Escalation Model Investigator: Corey Saba, DVM,…